Emmanuel Boleslawski
机构：Inserm, Université de Lille, Centre Hospitalier Universitaire de Lille, Lille’s Cardiology Hospital, Hôpital Claude Huriez, OncoThAI · ORCID：0000-0003-3286-8608
发表论文 236 篇 · 总被引 7354 次 · h-index 42
代表论文
- Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial (2024 · The Lancet · 被引 181)
- Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma (2023 · Nature Communications · 被引 84)
- Cholangiocarcinoma 2026: status quo, unmet needs and priorities (2025 · Nature Reviews Gastroenterology & Hepatology · 被引 78)
- Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma (2022 · Journal of Hepatology · 被引 39)
- Safety and feasibility of chemotherapy followed by liver transplantation for patients with definitely unresectable colorectal liver metastases: insights from the TransMet randomised clinical trial (2024 · EClinicalMedicine · 被引 37)
- Long-term outcome following liver transplantation of patients with ACLF grade 3 (2024 · Journal of Hepatology · 被引 36)